Mutual of America Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,994
Closed -$104K 1473
2023
Q3
$104K Sell
10,994
-1,222
-10% -$14.7K ﹤0.01% 1425
2023
Q2
$171K Sell
12,216
-616
-5% -$10.5K ﹤0.01% 1425
2023
Q1
$241K Sell
12,832
-196
-2% -$3.22K ﹤0.01% 1346
2022
Q4
$179K Buy
13,028
+726
+6% +$11.1K ﹤0.01% 1397
2022
Q3
$235K Buy
12,302
+1,932
+19% +$35.2K ﹤0.01% 1319
2022
Q2
$158K Buy
10,370
+1,497
+17% +$22.1K ﹤0.01% 1395
2022
Q1
$181K Buy
8,873
+492
+6% +$10K ﹤0.01% 1377
2021
Q4
$245K Buy
+8,381
New +$240K ﹤0.01% 1297

Other funds holding CDMO

Mutual of America Capital Management's CDMO Position: Q4 2023 in Review

Mutual of America Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2023, closing a stake of 10,994 shares — an estimated $104K sold.

Mutual of America Capital Management first reported a position in CDMO in Q4 2021 and held it in 8 quarters. The position peaked at $245K in Q4 2021. 175 funds tracked by Wall St. Rank hold CDMO as of Q4 2023.

  • Mutual of America Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Mutual of America Capital Management sold 10,994 Avid Bioservices, Inc. Common Stock shares in Q4 2023, an estimated $104K.
  • Mutual of America Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • Mutual of America Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $245K in Q4 2021.
  • 175 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2023.

Based on Mutual of America Capital Management's 13F filing for Q4 2023, filed 26 Jan 2024.